blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0604185

EP0604185 - Inhibitors of HIV protease useful for the treatment of AIDS [Right-click to bookmark this link]
Former [1994/26]Inhibitors of HIV protease useful for the treatment of aids
[1998/25]
StatusNo opposition filed within time limit
Status updated on  28.01.2000
Database last updated on 28.03.2026
Most recent event   Tooltip19.09.2003Lapse of the patent in a contracting state
New state(s): DK		published on 05.11.2003  [2003/45]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1994/26]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Jungheim, Louis Nickolaus
8218 Meadowbrook Drive
Indianapolis, Indiana 46240 / US
02 / Shepherd, Timothy Alan
8463 Slippery Elm Court
Indianapolis, Indiana 46227 / US
[1994/26]
Representative(s)Dehmel, Albrecht, et al
Bardehle Papenberg
Prinzregentenplatz 7
81675 München / DE
[N/P]
Former [1996/41]Dehmel, Albrecht, Dr. Dipl.-Chem., et al
Patent- und Rechtsanwälte Bardehle-Pagenberg-Dost-Altenburg- Frohwitter-Geissler & Partner Galileiplatz 1
81679 München / DE
Former [1994/26]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date93310359.020.12.1993
[1994/26]
Priority number, dateUS1992099525622.12.1992         Original published format: US 995256
US1993013432912.10.1993         Original published format: US 134329
[1994/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0604185
Date:29.06.1994
Language:EN
[1994/26]
Type: B1 Patent specification 
No.:EP0604185
Date:24.03.1999
Language:EN
[1999/12]
Search report(s)(Supplementary) European search report - dispatched on:EP23.03.1994
ClassificationIPC:C07D217/26, A61K31/47, C07D401/12, C07D401/06, A61K31/50
[1994/26]
CPC:
C07D401/06 (EP,US); C07D215/60 (KR); A61P31/12 (EP);
A61P31/18 (EP); C07D217/26 (EP,US); C07D401/12 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1994/26]
TitleGerman:HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS[1994/26]
English:Inhibitors of HIV protease useful for the treatment of AIDS[1998/25]
French:Inhibiteurs de la HIV protéase pour le traitement du SIDA[1994/26]
Former [1994/26]Inhibitors of HIV protease useful for the treatment of aids
Examination procedure03.01.1994Examination requested  [1994/26]
06.02.1995Despatch of a communication from the examining division (Time limit: M06)
13.09.1995Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.11.1995Reply to a communication from the examining division
27.12.1995Despatch of a communication from the examining division (Time limit: M08)
27.08.1996Reply to a communication from the examining division
12.09.1996Despatch of a communication from the examining division (Time limit: M06)
05.03.1997Reply to a communication from the examining division
25.07.1997Despatch of a communication from the examining division (Time limit: M04)
03.12.1997Reply to a communication from the examining division
06.05.1998Despatch of communication of intention to grant (Approval: Yes)
23.09.1998Communication of intention to grant the patent
23.12.1998Fee for grant paid
23.12.1998Fee for publishing/printing paid
Opposition(s)28.12.1999No opposition filed within time limit [2000/11]
Request for further processing for:07.11.1995Request for further processing filed
07.11.1995Full payment received (date of receipt of payment)
Request granted
27.11.1995Decision despatched
Fees paidRenewal fee
27.09.1995Renewal fee patent year 03
23.12.1996Renewal fee patent year 04
23.12.1997Renewal fee patent year 05
22.12.1998Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.03.1999
BE24.03.1999
CH24.03.1999
GR24.03.1999
LI24.03.1999
NL24.03.1999
DK24.06.1999
PT24.06.1999
[2003/45]
Former [2001/23]AT24.03.1999
BE24.03.1999
CH24.03.1999
GR24.03.1999
LI24.03.1999
NL24.03.1999
PT24.06.1999
Former [2000/52]AT24.03.1999
BE24.03.1999
CH24.03.1999
LI24.03.1999
NL24.03.1999
PT24.06.1999
Former [2000/50]AT24.03.1999
BE24.03.1999
NL24.03.1999
PT24.06.1999
CH29.06.1999
LI29.06.1999
Former [2000/23]AT24.03.1999
BE24.03.1999
NL24.03.1999
PT24.06.1999
Former [2000/21]AT24.03.1999
NL24.03.1999
Former [1999/36]NL24.03.1999
Cited inExamination  CHEMICAL & ENGINEERING NEWS, pages 4 - 5
   METHODS IN ENZYMOLOGY, pages 279 - 301
   LEHNINGER: "Biochemistry 2nd edition", WORTH PUBLISHERS INC., NEW YORK
   FITTKAU ET AL, BIOMED. BIOCHIM. ACTA, vol. 43, pages 901 - 907
   BARRETT ET AL, BIOCHEM. J., vol. 201, pages 189 - 198
   MA ET AL, PROC. NATL. ACAD. SCI. USA, vol. 89, pages 6275 - 6279
   TOUS ET AL, J.MED.CHEM., vol. 33, pages 1620 - 1634
   MILTON ET AL, SCIENCE, vol. 256, pages 1445 - 1448
   PETSKO, SCIENCE, vol. 256, pages 1403 - 1404
   CHEMICAL & ENGINEERING NEWS, pages 4 - 5
   METHODS IN ENZYMOLOGY, pages 279 - 301
   FITTKAU ET AL, BIOMED. BIOCHIM. ACTA, vol. 43, pages 901 - 907
   BARRETT ET AL, BIOCHEM. J., vol. 201, pages 189 - 198
   MA ET AL, PROC. NATL. ACAD. SCI. USA, vol. 89, pages 6275 - 6279
   TOUS ET AL, J.MED.CHEM., vol. 33, pages 1620 - 1634
   MILTON ET AL, SCIENCE, vol. 256, pages 1445 - 1448
   PETSKO, SCIENCE, vol. 256, pages 1403 - 1404
   LEHNINGER: "Biochemistry 2nd edition", WORTH PUBLISHERS INC., NEW YORK
by applicant  J. W. BARTON: "Protective Groups in Organic Chemistry", 1973, PLENUM PRESS
   T. W. GREENE: "Protective Groups in Organic Synthesis", 1981, JOHN WILEY AND SONS
   E. HASLAM: "Protective Groups in Organic Chemistry", 1973, PLENUM PRESS
   T.W. GREENE: "Protective Groups in Organic Synthesis", 1981, JOHN WILEY AND SONS
   VEDERAS ET AL., J.AM.CHEM. SOC., vol. 107, 1985, pages 7105 - 7109
   PHOTAKI, J. AM. CHEM. SOC., vol. 85, 1963, pages 1123
   SASAKI, N.A. ET AL., TETRAHEDRON LETTERS, vol. 28, 1987, pages 6069
   R. HERRANZ ET AL., J. ORA. CHEM., vol. 52, 1990, pages 2232 - 2234
   JACQUES ET AL.: "Enantiomers, Racemates, and Resolutions", 1981, JOHN WILEY & SONS
   MARGOLIN ET AL., BIOCHEM. BIONHVS. RES. COMMUN., vol. 167, 1990, pages 554 - 560
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.